GT Biopharma to Present at The Virtual 33rd Annual Roth Conference

BEVERLY HILLS, Calif., March 10, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate Cancer

BEVERLY HILLS, Calif., March 8, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

GT Biopharma Adds University of Wisconsin–Madison Carbone Cancer Center as Second Site in Ongoing Phase 1/2 Clinical Trial of GTB-3550 TriKE™, a Novel NK Cell Therapeutic Cancer Treatment

BEVERLY HILLS, Calif., March 4, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:…

“Pick & Shovel” Companies Could Provide Opportunity Within the Medical Industry in 2021

2021 May Bring New Potential for Emerging Trends in Healthcare

Havn Life Sciences to Host Investor Webcast on March 3, 2021

Attendees will have the opportunity to get the latest updates and participate…

Havn Life Announces DTC Eligibility of Its Common Shares in the United States

VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / Havn Life Sciences…

New Wave Holdings Launches Travel-Size Shower Powders in its Eco-Friendly Collection at Whole Foods Market U.S.

TORONTO, Feb. 3, 2021 /PRNewswire/ – NEW WAVE HOLDINGS CORP. (the “Company”…

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life to supply psychedelic compounds for clinical trials launched by neuroscience…

New Wave: Annouces that Bloom Botanics Ltd. will Launch a New Line of CBD Products in Europe under the brand name ‘Newtriment’

TORONTO, Feb. 1, 2021 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company”…